Abstract
This report indicates that stunted growth as part of the neonatal-onset multisystem inflammatory disease (NOMID) clinical scenery can be related to the skeletal picture of the disease itself, but also to growth hormone deficiency and that a substantial response to recombinant human growth hormone can be observed in NOMID.
Original language | English |
---|---|
Pages (from-to) | 101-105 |
Number of pages | 5 |
Journal | Clinical Pediatric Endocrinology |
Volume | 2018 |
DOIs | |
Publication status | Published - 2018 |
Keywords
- Growth Hormone